Business Wire

Project Management Institute President & CEO Sunil Prashara Announces Decision to Step Down

26.6.2021 07:01:00 EEST | Business Wire | Press release

Share

The Board of Directors of the Project Management Institute (PMI) stated today that Sunil Prashara, President & CEO, will be leaving PMI on December 31, 2021.

“It has been an honor to lead PMI,” Sunil said. “For the past year, I’ve been inspired by the heightened focus on Environmental, Social and Corporate Governance with respect to business and investment, and after careful consideration, I have decided to enroll in a full time Masters program at the London Business School (LBS). It will demand my full attention, which is why I made the difficult decision to step away from PMI. I love this organization and will miss the amazing people here with whom I’ve had the privilege to work and collaborate.”

Sunil continued: “I am grateful to have had the chance to help develop and advance the Institute’s strategy over the past two years. It has been an amazing journey: from the successful execution of PMI 2.0, to leading the growth mission of PMI 4.0 that substantially increased PMI’s relevance and visibility among stakeholder communities around the world. We created a regional model for PMI, enabling the Institute to efficiently serve global constituencies in unique ways that had never been done before. And we navigated the challenges of COVID-19, and kept our employees safe, while increasing revenue and providing added value to those we serve. PMI is on a strong path to advance its goals far into the future, and I couldn’t be more proud of what we have done together.”

He added, “I appreciate the support of PMI’s Executive Leadership Team and Board of Directors in reaching this decision and will work closely with them to ensure a smooth and seamless transition moving forward.”

“We are thankful for Sunil’s service to PMI and wish him the very best in his future endeavors,” stated Tony Appleby, Chair of the Board of Directors. “We have started the process of initiating a search for PMI’s next President & CEO. In the meantime, the Board has appointed Michael DePrisco to manage day-to-day organizational activities. We heartily welcome him to this role.”

Tony added: “The resilience of project management leaders around the world throughout the pandemic has been incredible. They’ve shown an ability to adapt to a changing world facing extraordinary challenges, and they raised the bar for everyone in our industry. The work being done at PMI today to support these hard-working professionals has never been more important, and we are excited by the many initiatives we have in store to further support and serve our great community. This is an exciting time for PMI, and we look forward to continuing our mission and delivering strong results for our members around the world.”

The Institute has over 650,000 members in nearly every country served by more than 320 chapters around the world. Over 1.9 million professionals have been certified by PMI.

PMI will share details regarding the search for PMI’s next President & CEO over the coming months.

About the Project Management Institute (PMI)

PMI is the world's leading professional association for a growing global community of millions of project professionals and changemakers worldwide.

As the world’s leading authority on project management, PMI empowers people to make ideas a reality. Through global advocacy, networking, collaboration, research, and education. PMI prepares organizations and individuals at every stage of their career journey to work smarter so they can drive success in a world of change.

Building on a proud legacy dating to 1969, PMI is a “for-purpose” organization working in nearly every country around the world to advance careers, strengthen organizational success, and enable changemakers with new skills and ways of working to maximize their impact. PMI offerings include globally recognized standards, certifications, online courses, thought leadership, tools, digital publications, and communities.

Visit us at: www.pmi.org, www.projectmanagement.com, LinkedIn, Facebook, and Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Project Management Institute (PMI)
Kerman Kasad
kerman.kasad@pmi.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 19:27:00 EET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye